menu search

MTP / Why Is Midatech Pharma (BDRX) Stock Up 64% Today?

Why Is Midatech Pharma (BDRX) Stock Up 64% Today?
Midatech Pharma (NASDAQ: BDRX ) stock is rocketing higher on Tuesday after the pharmaceutical company announced a new research program. According to a filing with the Securities and Exchange Commission (SEC). Read More
Posted: Mar 28 2023, 08:34
Author Name: InvestorPlace
Views: 083135

MTP News  

Why Is Midatech Pharma (BDRX) Stock Up 64% Today?

By InvestorPlace
March 28, 2023

Why Is Midatech Pharma (BDRX) Stock Up 64% Today?

Midatech Pharma (NASDAQ: BDRX ) stock is rocketing higher on Tuesday after the pharmaceutical company announced a new research program. According to a more_horizontal

Midatech Pharma plc continues to plummet on news of London delisting

By Proactive Investors
December 14, 2022

Midatech Pharma plc continues to plummet on news of London delisting

Midatech Pharma PLC (AIM:MTPH) fell another 13% to 3p on Wednesday, having now slashed its market valuation by half in the past five days. A day earli more_horizontal

Midatech Pharma boosted by European news on key product

By Proactive Investors
June 21, 2022

Midatech Pharma boosted by European news on key product

Midatech Pharma PLC (AIM:MTPH) is in demand after a positive European approval for a key product. The biotechnology company said that the European Me more_horizontal

Midatech Pharma's Shares Shoot Higher On FDA Fast Track Designation For Malignant Brain Tumor Drug

By Benzinga
June 1, 2022

Midatech Pharma's Shares Shoot Higher On FDA Fast Track Designation For Malignant Brain Tumor Drug

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ: MTP) lead drug candidate MTX110 for t more_horizontal


Search within

Pages Search Results: